MALT (drug)

MALT
Clinical data
Other names	N,N-Methylallyltyptamine; (2-(1H-Indol-3-yl)ethyl)(methyl)(prop-2-en-1-yl)amine; 1H-Indole-3-ethanamine, N-methyl-N-2-propen-1-yl-; Malt
Legal status
Legal status	UK: Class A; US: Analogue to a Schedule I/II drug; UN: Unscheduled; In general uncontrolled if is not sold for human consumption.;
Identifiers
	IUPAC name N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine;
CAS Number	1366416-29-6;
PubChem CID	155907915;
ChemSpider	74902443;
UNII	R3PSM6BEG8;
CompTox Dashboard (EPA)	DTXSID501337077 ;
Chemical and physical data
Formula	C14H18N2
Molar mass	214.312 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CN(CCC1=CNC2=CC=CC=C21)CC=C;
	InChI InChI=1S/C14H18N2/c1-3-9-16(2)10-8-12-11-15-14-7-5-4-6-13(12)14/h3-7,11,15H,1,8-10H2,2H3; Key:GXCLVBGFBYZDAG-UHFFFAOYSA-N;

MALT (N-methyl-N-allyltryptamine or N,N-methylallyltryptamine) is a lesser-known drug from the tryptamine family. It is a novel compound with very little history of human use. It is closely related to methylpropyltryptamine (MPT), as well as N-methyltryptamine. It has been sold online as a designer drug. Very little information on the pharmacology or toxicity of MALT is available.